https://scholars.lib.ntu.edu.tw/handle/123456789/596339
標題: | Do immunosuppressants cause posttransplant diabetes mellitus? | 作者: | CHEN-TU WU Wang W.-Y. Lin S.-L. Lee C.-J. |
關鍵字: | immunosuppressant; posttransplant diabetes mellitus; renal transplantation | 公開日期: | 1995 | 卷: | 55 | 期: | 1 | 起(迄)頁: | 37-41 | 來源出版物: | Chinese Medical Journal (Taipei) | 摘要: | Background. Posttransplant diabetes mellitus (PTDM) was originally described by Starzl in 1964. The incidence is around 3-46%, according to several reports. Etiologies and risk factors of PTDM have been discussed after it was described and recognized as a complication of renal transplantation. Methods. Twenty-five consecutive renal transplants in 24 recipients were reviewed, and 3 cases of posttransplant diabetes mellitus were found. Cyclosporine A (CsA), Azathioprine (Aza) dose and maintenance dose of Prednisolone (Pred.), rejection episodes, total dosage of steroid used at the time of acute rejection were carefully recorded and analyzed. Results. The mean age of 3 living-related and 22 cadaveric transplant recipients was 32.7 ± 7.5 and 33.5 ± 6.8 years in PTDM and non-PTDM patients, and the onset of PTDM was, on the average, 11.3 ± 0.6 months. Comparative studies between non-PTDM and PTDM groups showed that age, rejection episodes, total dose of methylprednisolone used in acute rejection, CsA level, and dosage of CsA, Aza and prednisolone at 1, 6, 12 and 24 months were not significantly different from one another. Conclusions. No significant risk factors or definitive mechanism involved in the development of PTDM were identified in this study. It is suggested that immunosuppressants are involved in the occurrence of PTDM, and probably neither a single factor is responsible nor is dose dependency involved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028964261&partnerID=40&md5=b40122ba1a4774abf311ba4fde58a4d5 https://scholars.lib.ntu.edu.tw/handle/123456789/596339 |
ISSN: | 0578-1337 | SDG/關鍵字: | azathioprine; cyclosporin; immunosuppressive agent; methylprednisolone; prednisolone; adult; article; clinical article; clinical trial; controlled clinical trial; controlled study; diabetes mellitus; female; graft rejection; human; kidney transplantation; male; oral drug administration; Adult; Diabetes Mellitus; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。